Hej Stockholm!
04/11/2024
Are you attending BIO EU in Stockholm? We are excited to catch up with old colleagues and meet new ones in this wonderful, vibrant city. Our team would love to buy you a coffee and find out about your development plans, be sure to connect with them while you are there.
Will you be at WODC?
25/09/2024
As established experts in the conduct of clinical trials in rare disease indications, we are excited to be attending WODC EU in Barcelona. Connect with us at the meeting or set up a CDA and book a time to discuss your requirements with our experts here. Set up my CDA now
Lets have coffee in Copenhagen!
19/09/2024
Our team are excited to be attending OCT Nordics! Connect with them there or book your meeting time today and we can ensure a CDA is in place for a more fruitful discussion in Copenhagen. Set up my CDA now
See you in Stockholm?
11/09/2024
We will be at BIO Europe in Stockholm. With the capability to shepherd your programme through the entire clinical development journey, talk to us and find out how we can guide you through to those crucial milestones. Get a jump start on meaningful discussion by setting up your CDA now
Klaria Sumatriptan Alginate Film Receives Marketing Authorization
02/09/2024
We are proud to have been trusted by Klaria to partner with them on this important project. Read their full press release here
Celebrating our colleagues
29/08/2024
We are proud that over 14% of our colleagues have been with Simbec-Orion for more than 10 years, 22% have tenure of 5-10 years. Our two longest serving colleagues have been with us for more than 40 years! You can meet one of them, Deborah Evans, Clinic Manager at our Phase I Unit here. Managing Director, […]
Simbec-Orion Employees Hear from Rare Disease Advocates
01/07/2024
Our experience of nearly 30 years conducting clinical trials in patients living with a rare diseases has brought us into contact with many different patient organisations. Today we were honoured to be joined by Rick Thomson, CEO of Beacon, a UK-based non-profit organisation that is building a united rare disease community to support patient groups. […]